Company Filing History:
Years Active: 2020
Title: Corinne Moulon: Innovator in Cancer Therapy
Introduction
Corinne Moulon is a prominent inventor based in Saint-Légier, Switzerland. She has made significant contributions to the field of cancer therapy through her innovative research and development of therapeutic methods.
Latest Patents
Corinne Moulon holds a patent for "Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)." This patent describes fusion polypeptides that include an FGFR2 polypeptide and cDNAs that encode such fusion polypeptides. Additionally, it outlines methods for diagnosing the presence of these fusion polypeptides or a gene or RNA sequence coding for them in a sample from a subject. The patent also details methods for treating tumors based on the results of the diagnosis.
Career Highlights
Corinne Moulon is associated with Debiopharm International S.A., a company known for its focus on innovative cancer therapies. Her work has been instrumental in advancing the understanding and treatment of cancer through targeted therapies.
Collaborations
Some of her notable coworkers include Hiroaki Tanaka and Anne Vaslin Chessex, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Corinne Moulon's work exemplifies the impact of innovative research in the field of cancer therapy. Her contributions continue to pave the way for advancements in treatment options for patients.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.